Evidence map›Paper›PMID 36267871›Full record

ArticleJHEP reports : innovation in hepatology2022

Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.

Diletta Overi, Guido Carpino, Laura Cristoferi, Paolo Onori, Lindsey Kennedy, Heather Francis, Nicola Zucchini, Cristina Rigamonti, Mauro Viganò, Annarosa Floreani and 10 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Role of Gut-Derived Endotoxins in Porto-Sinusoidal Vascular Disorder: Comparison Between patients with and without portal hypertension.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  3. Review
  4. Maternal Western Diet Programmes Bile Acid Dysregulation and Hepatic Fibrosis in Fetal and Juvenile Macaques.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Sequence of events leading to primary biliary cholangitis.World journal of gastroenterology · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 2 countries.

Diletta OveriDepartment of Anatomical, Histological, Forensic Medicine and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.
Guido CarpinoDepartment of Movement, Human and Health Sciences, Division of Health Sciences, University of Rome 'Foro Italico', Rome, Italy.
Laura CristoferiDivision of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Paolo OnoriDepartment of Anatomical, Histological, Forensic Medicine and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.
Lindsey KennedyHepatology and Gastroenterology, Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Heather FrancisHepatology and Gastroenterology, Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Nicola ZucchiniDivision of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Cristina RigamontiDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale 'A. Avogadro', Novara, Italy.
Mauro ViganòDivision of Hepatology, Ospedale San Giuseppe, University of Milan, Milan, Italy.
Annarosa FloreaniStudiosa Senior, University of Padua, Padua, Italy.
Daphne D'AmatoDivision of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Alessio GerussiDivision of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Rosanna VenereDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Gianfranco AlpiniHepatology and Gastroenterology, Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Shannon GlaserDepartment of Medical Physiology, Texas A&M University College of Medicine, Bryan, TX, USA.
Domenico AlvaroDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Pietro InvernizziDivision of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Eugenio GaudioDepartment of Anatomical, Histological, Forensic Medicine and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.
Vincenzo CardinaleDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
Marco CarboneDivision of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Sapienza University of Rome · ITAzienda Ospedaliera San Gerardo · ITRichard L. Roudebush VA Medical Center · USForo Italico University of Rome · ITTexas A&M University · USUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Milan · ITUniversity of Milano-Bicocca · ITUniversity of Padua · IT

Funding

Autocrine/Paracrine Regulation of Intrahepatic Bile Duct GrowthI01BX000574 · VA · RLR VA MEDICAL CENTER · PI ALPINI, GIANFRANCO D · 2009 to 2022
–
BLR&D Research Career Scientist AwardIK6BX004601 · VA · RLR VA MEDICAL CENTER · PI ALPINI, GIANFRANCO D · 2019 to 2025
–
BLRD VA I01 BX000574BLRD VA IK6 BX004601
6 · The paper itself

Abstract

Background & Aims: Primary biliary cholangitis (PBC) is a chronic cholangiopathy characterised by immuno-mediated injury of interlobular bile ducts leading to intrahepatic cholestasis and progressive liver fibrosis. PBC histology is characterised by portal inflammation, progressive fibrosis, ductopenia, and the appearance of the so-called ductular reaction. The aim of the present study was to investigate the pathogenetic relevance of ductular reaction in PBC. Methods: Liver biopsies were collected from naïve people with PBC (N = 87). Clinical-serological parameters were obtained at diagnosis and after 1 year of ursodeoxycholic acid (UDCA) treatment. Histological staging was performed on all slides according to multiple scoring systems and criteria for PBC. Liver samples were obtained from Results: Ductular reaction in people with PBC correlated with the disease stage and liver fibrosis, but not with disease activity; an extensive ductular reaction correlated with serum alkaline phosphatase levels at diagnosis, response to UDCA, and individuals' estimated survival, independently from other histological parameters, including disease stage. In people with PBC, reactive ductules were associated with the establishment of junctions with bile canaliculi and with fibrogenetic cell activation. Consistently, in a mouse model of intrahepatic cholestasis, UDCA treatment was effective in reducing ductular reaction and fibrosis and increasing ductular-canalicular junctions. Conclusions: Extensive ductular reaction outlines a severe histologic phenotype in PBC and is associated with an inadequate therapy response and a worse estimated prognosis. Lay summary: In people affected by primary biliary cholangitis (PBC), the histological appearance of extensive ductular reaction identifies individuals at risk of progressive fibrosis. Ductular reaction at diagnosis correlates with the lack of response to first-line therapy with ursodeoxycholic acid and serves to restore ductular-canalicular junctions in people with PBC. Assessing ductular reaction extension at diagnosis may add valuable information for clinicians.

Indexed as

AE2, anion exchanger 2ALP, alkaline phosphataseALPt0, ALP at diagnosisALPt12, ALP at 12 months after UDCA therapyALT, alanine aminotransferaseALTt0, ALT at diagnosisAMA, antimitochondrial antibodyANA, antinuclear antibodyAST, aspartate aminotransferaseASTt0, AST at diagnosisBAC, bile acid controlBIL, bilirubinBILt0, BIL at diagnosisCA, cholangitis activityCholangiopathyCholestasisCK19, cytokeratin 19CK7, cytokeratin 7DCJ/d, DCJ per ductuleDCJ, ductular–canalicular junctionDCJ/pt, DCJ per portal tractDR, ductular reactionEpCAM, epithelial cell adhesion moleculeGGT, gamma-glutamyl transferaseHA, hepatitis activityHistologyHSC, hepatic stellate cellIH, intermediate hepatocyteLiver biopsyMF, myofibroblastMuc-1, mucin 1PBC, primary biliary cholangitisPCNA, proliferating cell nuclear antigenRegenerationRT-qPCR, real-time quantitative PCRSCTR, secretin receptorSQ, semiquantitativeUDCA, ursodeoxycholic acidULN, upper limit of normalUrsodeoxycholic acidURS, UDCA response scoreWT, wild typeαSMA, α-smooth muscle actin

Identifiers

PMID36267871
PMCPMC9576897
OpenAlexW4298135852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.